Niremia Collective

Niremia Collective is a venture capital firm based in Silicon Valley, specializing in early-stage investments in wellness and health technology companies. The firm focuses on mental, emotional, and social health (MESH), aiming to enhance human potential through technological innovations. By integrating scientific knowledge from AI, neuroscience, and clinical psychology with digital technology, Niremia supports startups that promote personal growth and societal progress.

The firm's investment strategy emphasizes identifying solutions ahead of the curve by deeply analyzing social, technological, and scientific trends. Niremia seeks extraordinary teams with bold visions, substantial market opportunities, and evidence-based products that lead to positive behavior change. The firm is uniquely positioned to capitalize on the rapidly growing $8.5 trillion wellness and wellbeing market projected by 2027, leveraging its deep integration with the world's largest wellbeing tech ecosystem to provide proprietary access to exceptional deal flow and expert insights.

Niremia Collective's portfolio includes investments in companies such as Medmain, a Japanese pathology AI startup, and has established strategic partnerships with organizations like Shionogi & Co., Ltd. to support and nurture emerging companies in the wellbeing technology field. The firm's leadership includes co-founders Naoko Okumoto and Nichol Bradford, who bring extensive experience in technology investment and the wellbeing tech movement, respectively. Together, they drive Niremia Collective's mission to empower individuals through technology and foster a society centered on human flourishing.